Pharma Industry
Industry: Email Alert RSS FeedFDA approves doxycycline tablets, 150 mg
Journal of Drugs in Dermatology, August, 2007 by Marissa Heller
Mylan Laboratories Inc recently announced that it has received FDA approval for doxycycline tablets, 150 mg. This medication will be the equivalent generic version of Par Pharmaceutical's doxycycline tablets, 150 mg which are currently marketed by Doak Dermatologics under the brand name Adoxa[R] Tablets. Mylan already has approval and has been marketing doxycycline tablets in 50, 75, and 10 mg strengths.
Marissa Heller MD
Department of Dermatology, Boston University School of Medicine
Most RecentPharma Articles
Pipeline Previews brings you information on the newest drugs and medical products as they become available to the dermatologic community. These features may include additional information from the manufacturers, plus reports from physicians who wish to share their clinical experience with these new products. In addition, we will inform our readers about the latest drugs receiving FDA approval. We trust you will find this information beneficial to your practice and research.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- La anemia falciforme - causas y tratamiento



